In addition to the clinical applications of D-mannose in treating cancer, urinary infections, type 1 diabetes, and diabetic wounds, we also support the potential of D-mannose as a therapeutic strategy for depression and other neuropsychiatric disorders through its actions on ACSS2. This evidence concerns the gene ACSS2 and type 1 diabetes mellitus.